Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues

Thyroid

Volumn 22, Issue 5, 2012, Pages 529-535

  Kollecker, Inga ^a,f   Von Wasielewski, Reinhard ^a,g   Langner, Cord ^b   Müller, Jörg Andreas ^a   Spitzweg, Christine ^c   Kreipe, Hans ^a   Brabant, Georg ^d,e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e CHRISTIE HOSPITAL   (United Kingdom)

^f KLINIKUM BRAUNSCHWEIG   (Germany)

^g Institute of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ANTIBODY AFFINITY; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG UPTAKE; FETUS (ANATOMY); GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; METASTASIS; ONCOCYTOMA; PRIORITY JOURNAL; RECURRENT DISEASE; SUBACUTE THYROIDITIS; THYROID ADENOMA; THYROID CARCINOMA; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TOXIC GOITER; UNDIFFERENTIATED CARCINOMA;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HASHIMOTO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; IODIDES; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RETROSPECTIVE STUDIES; SYMPORTERS; THYROGLOBULIN; THYROID GLAND; THYROIDITIS; TISSUE DISTRIBUTION;

EID: 84860425402     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0311     Document Type: Article

References (40)

1. Riesco-Eizaguirre G, Santisteban P 2006 A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 155:495-512.
2. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379:458-460.
3. Spitzweg C, Joba W, Eisenmenger W, Heufelder AE 1998 Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland and gastric mucosa. J Clin Endocrinol Metab 83:1746-1751.
4. Spitzweg C, Heufelder AE, Morris JC 2000 Thyroid iodine transport. Thyroid 10:321-330.
5. Carvalho DP, Ferreira ACF 2007 The importance of sodium/ iodide symporter (NIS) for thyroid cancer management. Arq Bras Endocrinol Metabol 51:672-682.
6. Dohán O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N 2003 The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48-77.
7. Riedel C, Levy O, Carrasco N 2001 Post-transcriptional regulation of the odium/iodide symporter by thyrotropin. J iol Chem 276:21458-21463.
8. Kaminsky SM, Levy O, Salvador C, Dai G, Carrasco N 1994 N+ -I - Symport activity is present in membrane vesicles from thyrotropin-deprived non-I - transporting cultured thyroid cells. Biochemistry 91:3789-3793.
9. Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A, Onaya T 1998 Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J Clin Invest 101:1296-1300.
10. Trouttet-Masson S, Selmi-Ruby S, Bernier-Valentin F, Porra V, Berger-Dutrieux N, Decaussin M, Peix JL, Perrin A, Bournaud C, Orgiazzi J, Borson-Chazot F, Franc B, Rousset B 2004 Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors. Am J Pathol 165:25-34.
11. Böcker W, Dralle H, Hüsselmann H, Bay V, Brassow M 1980 Immunohistochemical analysis of thyroglobulin synthesis in thyroid carcinomas. Virchows Arch Anat Histol 385:187-200.
12. Ryff-De Lèche A, Staub JJ, Kohler-Faden R, Müller-Brand J, Heitz PU 1986 Thyroglobulin production by malignant thyroid tumors. Cancer 57:1145-1153.
13. Roelants V, De Nayer P, Bouckaert A, Beckers C 1997 The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 24:722-727.
14. Pacini F, Castagna MG, Brilli L, Pentheroudakis G 2010 Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v214-v219.
15. Lazar V, Bidart JM, Caillou B, Mahè C, Lacroix L, Filetti S, Schlumberger M 1999 Expression of the Na+ /I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Endocrinol Metab 84:3228-3234.
16. Arturi F, Russo D, Schlumberger M, Du Villard JA, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez HG, Filetti S 1998 Iodide symporter gene expression in human thyroid tumors. J Endocrinol Metab 83:2493-2496.
17. Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC 1999 Monoclonal antibodies against the human sodium iodide symporter: utility for immunohistochemistry of thyroid cancer. J Endocrinol 163:495-504.
18. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC 2001 Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab 86:5627-5632.
19. Dohan O, Baloch Z, Bánrèvi Z, Livolsi V, Carrasco N 2001 Predominant intracellular overexpression of the Na+ /I - symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab 86:2697-2700.
20. Wapnir IL, Van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohán O, Carrasco N 2003 Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 88:1880-1888.
21. Min JJ, Chung JK, Lee YJ, Jeong JM, Lee DS, Jang JJ, Lee MC, Cho BY 2001 Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med 28:639-645.
22. Jhiang SM, Cho JY, Ryu KY, De Young BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL 1998 An immunohistochemical study of Na+ /I - symporter in human thyroid tissues and salivary gland tissue. Endocrinology 39:4416-4419.
23. Peyrottes I, Navarro V, Ondo-Mendez A, Marcellin D, Bellanger L, Marsault R, Lindenthal S, Ettore F, Darcourt J, Pourcher T 2009 Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancer. Eur J Endocrinol 160:215-225.
24. Mishra A, Pal L, Mishra SK 2007 Distribution of Na+ /I - Symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study. World J Surg 31:1737-1742.
25. Lee SJ, Choi KC, Han JP, Park YE, Choi MG 2007 Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas. J Endocrinol Invest 30:28-34.
26. Caillou B, Troalen F, Baudin E, Talbot M, Filetti S, Schlumberger M, Bidart JM 1998 Na+ /I - symporter distribution in human thyroid tissues: an immunohistochemical study. J Clin Endocrinol Metab 83:4102-4106.
27. Gèrard AC, Daumerie C, Mestdagh C, Gohy S, de Burbure C, Costagliola S, Miot F, Nollevaux MC, Denef JF, Rahier J, Franc B, De Vijlder JJM, Colin IM, Many MC 2003 Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Endocrinol Metab 88:4977-4983.
28. Schmitz G, Füzesi L, Struck J, Siefker U, Hamann A, Sahlmann CO, Hüfner M 2005 Expression of the sodium iodide symporter in differentiated thyroid cancer. Nuklearmedizin 44:86-93.
29. Sodrè AKMB, Rubio IGS, Galrão ALR, Knobel M, Tomimori EK, Alves VAF, Kanamura CT, Buchpiguel CA, Watanabe T, Friguglietti CKM, Kulcsar MAV, Medeiros-Neto G, Camargo RYA 2008 Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining. J Clin Endocrinol Metab 93:4141-4145.
30. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M 1999 Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 141:443-457.
31. Arturi F, Russo D, Giuffrida D, Schlumberger M, Filetti 2000 Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas. Eur J Endocrinol 143:623-627.
32. Park HJ, Kim JY, Park KY,Gong G, Hong SJ, Ahn IM 2000 Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid 10:211-217.
33. Mengel M, Kreipe H, von Wasielewski R 2003 Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems. Appl Immunohistochem Mol Morphol 11:261-268.
34. Studer H, Peter HJ, Gerber H 1989 Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev 10:125-135.
35. Szinnai G, Lacroix L, Carrè A, Guimiot F, Talbot M, Martinovic J, Delezoide AL, Vekemans M, Michiels S, Caillou B, Schlumberger M, Bidart JM, Polak M 2007 Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid funcion in the human fetus. J Endocrinol Metab 92:70-76.
36. Mian C, Lacroix L, Alzieu L, Nocera M, Talbot M, Bidart JM, Schlumberger M, Caillou B 2001 Sodium iodide symporter and pendrin expression in human thyroid tissue. Thyroid 11:825-830.
37. Larsen PR 1975 Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. J Clin Endocrinol Metab 41:1098-1104.
38. Leoni SG, Kimura ET, Santisteban P, De la Vieja A 2011 Regulation of thyroid oxidative state by thioredoxin reductase has a crucial role in thyroid response to iodide excess. Mol Endocrinol 25:1924-1935.
39. Morari EC, Marcello MA, Guilhen AC, Cunha LL, Latuff P, Soares FA, Vassallo J, Ward LS 2011 Use of sodium iodide symporter expression in differentiated thyroid carcinomas. Clin Endocrinol 75:247-254.
40. Liu XH, Chen GG, Vlantis AC, van Hasselt CA 2009 Iodine mediated mechanisms and thyroid carcinoma. Crit Rev Clin Lab Sci 46:302-318.